PharMerica Receives Consensus Rating of “Buy” from Analysts (NYSE:PMC)
PharMerica (NYSE:PMC) has been given a consensus recommendation of “Buy” by the seven ratings firms that are presently covering the company, StockRatingsNetwork.com reports. One research analyst has rated the stock with a sell recommendation and five have issued a buy recommendation on the company. The average 1-year price target among brokerages that have issued ratings on the stock in the last year is $29.68.
PMC has been the subject of a number of recent research reports. Analysts at Cowen and Company upgraded shares of PharMerica from a “market perform” rating to an “outperform” rating in a research note on Wednesday. They now have a $33.00 price target on the stock, up previously from $31.00. Separately, analysts at Zacks upgraded shares of PharMerica from a “neutral” rating to an “outperform” rating in a research note on Friday, August 8th. They now have a $31.40 price target on the stock. Finally, analysts at Barclays initiated coverage on shares of PharMerica in a research note on Thursday, July 17th. They set an “underweight” rating on the stock.
PharMerica (NYSE:PMC) traded down 0.08% on Friday, hitting $25.48. The stock had a trading volume of 19,302 shares. PharMerica has a 52 week low of $12.15 and a 52 week high of $30.48. The stock’s 50-day moving average is $26.33 and its 200-day moving average is $27.04. The company’s market cap is $765.9 million.
PharMerica (NYSE:PMC) last posted its quarterly earnings results on Tuesday, August 5th. The company reported $0.40 earnings per share for the quarter, beating the analysts’ consensus estimate of $0.36 by $0.04. The company had revenue of $448.60 million for the quarter, compared to the consensus estimate of $432.70 million. During the same quarter last year, the company posted $0.44 earnings per share. PharMerica’s revenue was up 4.1% compared to the same quarter last year. On average, analysts predict that PharMerica will post $1.52 earnings per share for the current fiscal year.
PharMerica Corporation is an institutional pharmacy services company, which services healthcare facilities and provides management pharmacy services to hospitals.